Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bowel (colorectal) cancer, Rectal cancer
Closed
Phase 3
This trial is looking at adding irinotecan to the standard treatment for rectal cancer.
It is for people who have cancer that started in the and has spread into the surrounding tissues ().
This trial is supported by Cancer Research UK.
Recruitment start: 22 September 2011
Recruitment end: 29 June 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Sebag-Montefiore
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University College London (UCL)
This is Cancer Research UK trial number CRUK/08/032.
Last reviewed: 28 Jun 2018
CRUK internal database number: 1006
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
